Published in Intern Emerg Med on February 01, 2010
Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int (2016) 0.78
Rapid urease test for H. pylori diagnosis: pros and cons. Intern Emerg Med (2010) 0.75
Real-time diagnosis of H. pylori infection during endoscopy: Accuracy of an innovative tool (EndoFaster). United European Gastroenterol J (2015) 0.75
A Novel stool PCR Test for Helicobacter pylori may Predict Clarithromycin Resistance and Patient Eradication at a High Rate. J Clin Microbiol (2017) 0.75
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med (2007) 5.62
Susceptibility of Helicobacter pylori to metronidazole. Am J Gastroenterol (2003) 1.98
Celiac disease with mild enteropathy is not mild disease. Clin Gastroenterol Hepatol (2012) 1.90
Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol (2012) 1.83
High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis (2011) 1.54
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci (2004) 1.51
Intestinal tuberculosis. Curr Opin Infect Dis (2009) 1.47
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. Dig Liver Dis (2013) 1.43
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
The stool antigen test for detection of Helicobacter pylori after eradication therapy. Ann Intern Med (2002) 1.25
Inflammatory bowel disease: is the intestine a Trojan horse? Sci Prog (2002) 1.22
Diagnosis of Helicobacter pylori: invasive and non-invasive tests. Best Pract Res Clin Gastroenterol (2007) 1.19
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother (2009) 1.16
Observations on the paper of Carroccio et al. "non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity". Am J Gastroenterol (2013) 1.13
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis. J Infect Dis (2006) 1.11
Precise role of H pylori in duodenal ulceration. World J Gastroenterol (2006) 1.11
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air. Curr Med Res Opin (2014) 1.09
Helicobacter: a paradigm shift in peptic ulcer disease and more? Sci Prog (2002) 1.09
The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res (2005) 1.09
Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. J Pathol (2004) 1.06
Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells. Mol Cancer Ther (2006) 1.06
Does Helicobacter pylori really cause duodenal ulcers? No. BMJ (2009) 1.05
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol (2005) 1.05
Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol (2003) 1.04
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res (2004) 1.04
Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol (2004) 1.00
Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis (2013) 0.98
A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study. Eur J Gastroenterol Hepatol (2012) 0.95
Widespread occurrence of Mycobacterium tuberculosis DNA from 18th-19th century Hungarians. Am J Phys Anthropol (2003) 0.95
Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology (2007) 0.94
The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication. J Clin Gastroenterol (2009) 0.93
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. J Gastrointestin Liver Dis (2012) 0.92
Innate immunity and pathogen-host interaction. Vaccine (2003) 0.91
Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol (2004) 0.91
Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection. Clin Gastroenterol Hepatol (2012) 0.91
Five year time course of celiac disease serology during gluten free diet: results of a community based "CD-Watch" program. Dig Liver Dis (2010) 0.90
Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now! Therap Adv Gastroenterol (2009) 0.90
Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system. Gut Microbes (2011) 0.89
Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter (2004) 0.87
Peptic ulcer and Helicobacter pylori: update on testing and treatment. Postgrad Med (2005) 0.87
Newer agents for Helicobacter pylori eradication. Clin Exp Gastroenterol (2012) 0.86
Controversies in the Helicobacter pylori/duodenal ulcer story. Trans R Soc Trop Med Hyg (2008) 0.83
Descending perineum syndrome: are abdominal hysterectomy and bowel habits linked? Dis Colon Rectum (2005) 0.83
Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials. Ann Med (2014) 0.83
Cholera-like enterotoxins and Regulatory T cells. Toxins (Basel) (2010) 0.82
Actual concept of "probiotics": is it more functional to science or business? World J Gastroenterol (2013) 0.82
Improving vital sign documentation at triage: an emergency department quality improvement project. J Patient Saf (2011) 0.82
Presence of Helicobacter pylori in betel chewers and non betel chewers with and without oral cancers. BMC Oral Health (2009) 0.82
Clinical expression of lymphocytic duodenosis in "mild enteropathy" celiac disease and in functional gastrointestinal syndromes. Scand J Gastroenterol (2014) 0.81
Celiac disease in elderly adults: clinical, serological, and histological characteristics and the effect of a gluten-free diet. J Am Geriatr Soc (2012) 0.81
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Neuropharmacology (2013) 0.81
Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c-myc and bcl-2 expression. Cell Tissue Res (2004) 0.81
A human domain antibody and Lewis b glycoconjugate that inhibit binding of Helicobacter pylori to Lewis b receptor and adhesion to human gastric epithelium. J Infect Dis (2009) 0.81
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. J Med Microbiol (2013) 0.80
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. J Clin Apher (2011) 0.80
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis. Int J Antimicrob Agents (2008) 0.80
Time-domain and morphological analysis of the P-wave. Part I: Technical aspects for automatic quantification of P-wave features. Pacing Clin Electrophysiol (2008) 0.80
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother (2003) 0.80
Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity. World J Gastroenterol (2006) 0.80
Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model. Dis Colon Rectum (2007) 0.79
Comparison of image analysis software packages in the assessment of adhesion of microorganisms to mucosal epithelium using confocal laser scanning microscopy. J Microbiol Methods (2005) 0.79
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire. Intern Emerg Med (2010) 0.79
Time-domain and morphological analysis of the P wave. Part II: effects of atrial pacing on P-wave features. Pacing Clin Electrophysiol (2008) 0.79
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules. Oncol Res (2005) 0.79
Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C. J Gastroenterol Hepatol (2007) 0.78
Gastroesophageal reflux disease and Barrett's esophagus. Intern Emerg Med (2010) 0.78
Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr (2011) 0.77
Errors in a meta-analysis of treatments for Helicobacter pylori infection. Ann Intern Med (2008) 0.77
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? Nat Clin Pract Gastroenterol Hepatol (2007) 0.77
Use of a single biopsy specimen for diagnosing Helicobacter pylori infection by culture and two different PCR methods: report from Cuba. Trop Gastroenterol (2010) 0.77
Treatment of Helicobacter pylori in Latin America. Lancet (2012) 0.77
Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomized controlled trial. J Clin Gastroenterol (2009) 0.77
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: an appealing scaffold for the design of Rac1-Tiam1 protein-protein interaction inhibitors. J Med Chem (2014) 0.77